Please join the Hadassah Northeast Advocacy and Action Committee (HAAC) and the Consulate General of Israel to New England for a program exploring groundbreaking Israeli biotech innovation taking place right here in New England.
Our panel of three distinguished industry leaders will share insights into emerging innovations that are shaping the future of healthcare and discuss the benefits and challenges of bringing Israeli entrepreneurship to Massachusetts.
Our panelists:
- Luba Perry, Ph.D.: Founder and CEO of ReConstruct Bio, developer of personalized living tissue implants, focusing initially on post-mastectomy breast reconstruction.
- Miri Polachek: Co-founder and CBO of Nuri Braintech, developer of a brain/computer interface for severe treatment-resistant psychiatric conditions, including PTSD.
- Iris Shtein: Co-founder and CEO of Mentaily, developer of a mental health platform utilizing a GenAI model for personalized clinical decision support.
CJP provides the above links concerning third-party events for your convenience only. CJP has no control over the content of the linked-to websites or events they describe, and accepts no responsibility for the websites, including any advertising or products or services on or available from such sites, or for any loss or damage that may arise from your attending, or registering to attend, the described events. If you decide to access any of the third-party websites linked to below, you do so entirely at your own risk and subject to the terms and conditions of use for such websites and event attendance. CJP is not responsible or liable to you or any third party for the content or accuracy of any materials provided by any third parties. All statements and/or opinions expressed in the linked-to materials or at the described events, and all commentary, articles and other content provided at the third-party websites or at the events, are solely the opinions and the responsibility of the persons or entities operating the linked-to websites and events. The inclusion of any link on this website does not imply that CJP endorses the described event, or the linked-to website or its operator. MORE
